Document ID: chunk:federal_register_of_legislation:F2021L01332:reg:7
Version: federal_register_of_legislation:F2021L01332
Segment Type: reg
Provision Reference: reg 7
Character Range: 10584–12401

7  Transitional arrangements
 (1) In this section:
  former instruments means the:
 (a) Therapeutic Goods Order No. 83 Standards for human musculoskeletal tissue, as in force immediately before the commencement of the repeal instrument; and
 (b) Therapeutic Goods Order No. 84 Standards for human cardiovascular tissue, as in force immediately before the commencement of the repeal instrument; and
 (c) Therapeutic Goods Order No. 85 Standards for human ocular tissue, as in force immediately before the commencement of the repeal instrument; and
 (d) Therapeutic Goods Order No. 86 Standards for human skin, as in force immediately before the commencement of the repeal instrument.
  former provisions means the following provisions of the Therapeutic Goods Order No. 88 Standards for donor selection, testing, and minimising infectious disease transmission via therapeutic goods that are human blood and blood components, human tissues and human cellular therapy products, as in force immediately before the commencement of the repeal instrument:
 (a) subsection 9(13); and
 (b) subsection 9(14); and
 (c) subsection 9(15); and
 (d) section 12; and
 (e) section 13.
  repeal instrument means the Therapeutic Goods (Standards for Biologicals) Repeal Instrument 2021.
  transition period means the period beginning on 30 September 2021 and ending on 30 September 2022.
 (2) Despite the repeal of the former instruments and former provisions by the repeal instrument, the former instruments and former provisions continue to apply for the duration of the transition period, such that the standards for biologicals constituted by the former instruments and former provisions may be conformed with as an alternative to the standards for biologicals constituted by this instrument.

Part 2—Standard for all biologicals